Global Transcranial Magnetic Stimulation Market Research Report: Forecast (2025-2030)

Market Definition

Transcranial magnetic stimulation (TMS) is a procedure to treat brain-related disorders and is used when all other solutions are ineffective. In this procedure, magnetic fields are passed through a desired area of the brain to make the nerves of that area more active and cure mental disorders.

Market Insights & Analysis: Global Transcranial Magnetic Stimulation Market (2025-30):

The Global Transcranial Magnetic Stimulation Market size was valued at around USD 1.34 billion in 2024 and is projected to reach USD 2.26 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period, i.e., 2025-30. The main reason behind this growth is the rising awareness among people about the use case of TMS for treating several disorders like depression, Alzheimer’s disease, migraine, stroke rehabilitation, etc. This results in an increasing number of such patients getting their disorders treated. As a result, the demand for TMS systems increases at the health centers, thus pushing the market toward growth.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, various insurance policies cover the TMS treatment for several neurological brain disorders, which are becoming common, mainly depression and OCD. This may vary as per country. For instance, in the US, the majority of private insurance providers cover TMS treatment therapies. Similarly, in Australia, TMS therapy was included in the Medical Benefits Schedule (MBS) in 2021, due to which major insurance has TMS treatment covered. Similar trends have been noticed in various countries such as the Netherlands, where there is a great demand for TMS systems, thereby giving TMS manufacturers a beneficial setting for expansion across multiple countries. Parkinson's disease affects about 90,000 people annually only in the United States.

Furthermore, supporting the fact that it is most common among seniors because of the increasing proportion of the age group. For example, around 96% of cases come in people over 50 years of age. Such issues would drive demand for TMS therapies and hence rise in the growth of this market. Another factor behind the growth of this market is the coverage of this treatment in insurance policies, which is expected to continue over the next few years. The increasing incidence of several psychiatric conditions in recent years, as well as expanding consumer knowledge, has therefore helped to drive sales of TMS systems.

Global Transcranial Magnetic Stimulation Market Driver:

Rising Cases of Brain-Related Neurological Disorders Across the World – There has been a notable trend in the rising number of cases of brain disorders in the world. These occur due to the improper functioning of brain nerves. For instance, as per the WHO, there are more than 1 billion people worldwide who face some kind of mental disorder in 2023. These problems have to be treated as early as possible, and if ignored, they can go on for months, sometimes years, thus affecting a person’s life. Hence, the demand for TMS increases for its utilization in treating mental disorders in clinics, hospitals, and diagnostic centers. With an increase in cases related to mental disorders, there has been a high use of TMS in healthcare which in turn creates high demand for this equipment, and this trend is expected to increase in the forecast years as well.

Global Transcranial Magnetic Stimulation Market Opportunity:

Ongoing Research to Expand the Use of TMS for Treating Several Neurological Disorders – Various companies are utilizing the TMS system to treat brain-related neurological problems other than depression. For instance, BrainsWay Deep TMS was used for the treatment of depression after it got approval in 2013 but was awarded approval for the treatment of OCD in 2017. Similar advancements have been noted in devices manufactured by various companies regarding problems such as migraine, neurorehabilitation, etc. As a result, various healthcare providers have to upgrade their TMS devices to align with the latest technology to have better functionality and provide efficient treatment to patients. Thus giving opportunities to the market to increase their production to meet the growing demand for TMS. Therefore, research & development have been ongoing to expand the use of TMS devices, and this will increase their popularity in the coming years as well, thus providing a good growth opportunity for the market.

Global Transcranial Magnetic Stimulation Market Challenge:

Lack of Investment in Mental Healthcare – There is a very small proportion of hospitals and clinics that have invested in mental health solutions. This could be observed from the latest Mental Health Atlas released by the WHO in 2021, which shows that there is a very high need to scale up the quality of mental health services to align with the current needs. This lack of investment is due to the lower inclination of people towards the treatment of mental disorders. There are two main reasons behind this; the first is the high cost of treatment, and the other is the social stigma associated with mental disorders.

As a result, healthcare providers are less inclined towards availing mental healthcare solutions in their services, thus affecting the sales of the TMS machinery. Therefore, the lack of investments in mental healthcare due to less number of associated patients opting for treatment will present a challenge to the growth of the market.

Global Transcranial Magnetic Stimulation Market Trend:

Time-Efficient TMS Systems Gaining Traction – Various makers of TMS systems are highly focused on developing machines that can perform the treatment process in the least possible time. This is because shorter sessions provide comfort to the patient while being cost-efficient. Additionally, such systems also allow healthcare providers to provide therapies to more patients. For instance, MagVenture announced to collaborate with Magnus Medical in 2024 to develop and launch the SAINT Neuromodulation System, a TMS with highly efficient in the quick treatment of depression. This results in an increase in sales of such systems as they attract a wide consumer base.

Therefore, time-efficient TMS systems have attracted a lot of patients in recent years as they are cost and time-efficient, and this trend is expected to remain in the coming years as well, thus showing a growth environment for the market.

Global Transcranial Magnetic Stimulation Market (2025-30): Segmentation Analysis

The Global Transcranial Magnetic Stimulation Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–30 at the global level. Based on the analysis, the market has been further classified as:

Based on Type:

• Deep Transcranial Magnetic Stimulation
• Repetitive Transcranial Magnetic Stimulation
• Others

Based on the type, repetitive transcranial magnetic stimulation (rTMS) leads the market with a share of around 52%. This is because rTMS is a traditional solution that was approved by the FDA in 2008, due to which this method can be easily accessed at various hospitals and clinics. Additionally, this method does not cause memory loss, which is frequent in other solutions. Also, the chances of remission of disorder symptoms are very low with this method. For instance, less than 30% of patients face remission of symptoms when treated with rTMS, whereas this number was around 65% when treated with dTMS.

Moreover, this treatment's side effects are less than other alternatives. Therefore, the safe and well-tolerated treatment offered by rTMS is the reason behind this segment’s dominance, which is expected to remain in the future as well.

Based on Application:

• Depression Treatment
• Tinnitus Treatment
• Alzheimer’s Disease Treatment
• Epilepsy Treatment
• Stroke Rehabilitation
• Parkinson’s Disease treatment
• Others

Alzheimer’s disease is mainly treated using the TMS system, thus holding a market share of around 40%. This is because of the growing number of cases of such patients. For instance, as per the WHO, there were about 55 million people worldwide facing Alzheimer’s disease in 2023, and this number grew by approximately 10 million new cases every year. More conditions under this disease include bipolar disorder, autism, multiple sclerosis, and schizophrenia. All such patients are recommended by the healthcare providers to get TMS therapy. As a result, the high number of patients with this kind of disease has pushed healthcare providers to invest in the TMS systems for treating it. Therefore, the high prevalence of Alzheimer’s disease has created the highest demand for TMS systems, thus contributing the most to this market’s growth, and this dominance is expected to remain in the forecast period as well.

Global Transcranial Magnetic Stimulation Market (2025-30): Regional Projections

Geographically, the Global Transcranial Magnetic Stimulation Market expands across:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Regionally, North America leads the market with a share of around 36%. This is because of the large number of patients in North America who are suffering from various types of mental disorders. For instance, around 21 million American adults suffered from major depressive disorder (MDD) in 2023. Additionally, the high income of people in this region and high awareness about the magnetic stimulation treatment system further push people towards getting the treatment. As a result, the sales of TMS systems increase to fulfill the growing demand.

Moreover, the presence of a high number of TMS makers in this region and their high investments in research and development processes further fuel the growth of the market. Therefore, due to high awareness and wide availability of treatment, the region’s dominance can be seen, and this dominance is expected to continue in the future as well.

Global Transcranial Magnetic Stimulation Industry Recent Development:

• 2024: BrainsWay gets its 10^th FDA approval for its Deep TMS system. With this approval, the upper age limit for the treatment-eligible person is changed from 68 to 86. It becomes the first company to achieve a label for late-life depression treatment.
• 2024: Magstim launched the Horizon Inspire TMS system and got clearance from the FDA to treat depression, OCD, and anxious depression. The system is user-friendly, cost-effective, and does not have a pay-per-use.

Gain a Competitive Edge with Our Global Transcranial Magnetic Stimulation Market Report

1. Global Transcranial Magnetic Stimulation Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & market share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Global Transcranial Magnetic Stimulation Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.